ACT Lab Researchers Participate in the 22nd Portuguese Congress of Diabetology

Two researchers from the ACT Lab, Cláudia Deus and Sandra Pinhanços, participated in the Portuguese Congress of Diabetology, which took place in Vilamoura from 5 to 7 March 2026. The congress brought together clinicians and researchers from across the country to discuss the latest advances in diabetes research, prevention, and treatment.

During the meeting, Cláudia Deus presented a poster entitled “Papel do miRNA-642-3p na disfunção metabólica e mitocondrial induzida pela glucolipotoxicidade em células pancreáticas.” The work explores the role of miRNA-642-3p in the metabolic and mitochondrial dysfunction triggered by glucolipotoxic conditions in pancreatic cells.

Sandra Pinhanços contributed to the scientific program with an oral presentation titled “miRNAs como guardiões das células β contra a glucolipotoxicidade.” Her presentation highlighted the protective role of microRNAs in safeguarding pancreatic β-cells against glucolipotoxic stress.

The participation of ACT Lab researchers in this national meeting reflects the group’s ongoing commitment to advancing knowledge on metabolic dysfunction and pancreatic β-cell biology in the context of diabetes.

Site: https://www.congressodiabetes.com/_homex.aspx

Sandra Pinhanço’s oral presentation.

Cláudia Deus´s poster.